Free Trial

HCA Healthcare, Inc. $HCA Shares Acquired by Canoe Financial LP

HCA Healthcare logo with Medical background

Key Points

  • Canoe Financial LP has increased its stake in HCA Healthcare by 0.5%, acquiring an additional 773 shares, bringing its total to 164,896 shares valued at approximately $63.2 million.
  • HCA Healthcare reported a quarterly EPS of $6.84, exceeding analysts' expectations, with quarterly revenues totaling $18.61 billion.
  • The company has announced a quarterly dividend of $0.72 per share, with a dividend payout ratio currently at 12.11%.
  • Five stocks we like better than HCA Healthcare.

Canoe Financial LP raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 164,896 shares of the company's stock after purchasing an additional 773 shares during the period. Canoe Financial LP owned 0.07% of HCA Healthcare worth $63,172,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Exchange Traded Concepts LLC raised its stake in HCA Healthcare by 70.2% during the second quarter. Exchange Traded Concepts LLC now owns 24,719 shares of the company's stock worth $9,470,000 after acquiring an additional 10,193 shares in the last quarter. Vista Investment Partners LLC boosted its holdings in HCA Healthcare by 0.8% during the second quarter. Vista Investment Partners LLC now owns 8,574 shares of the company's stock worth $3,285,000 after buying an additional 66 shares during the last quarter. Wedmont Private Capital boosted its holdings in HCA Healthcare by 4.3% during the second quarter. Wedmont Private Capital now owns 3,476 shares of the company's stock worth $1,316,000 after buying an additional 144 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of HCA Healthcare by 3.8% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 25,421 shares of the company's stock valued at $9,739,000 after purchasing an additional 925 shares in the last quarter. Finally, Sivia Capital Partners LLC lifted its holdings in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock valued at $241,000 after purchasing an additional 33 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Up 0.1%

Shares of HCA Healthcare stock traded up $0.37 during trading on Tuesday, hitting $407.61. 240,590 shares of the stock were exchanged, compared to its average volume of 1,530,065. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98. The stock has a market cap of $95.38 billion, a price-to-earnings ratio of 17.13, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm's 50-day moving average price is $385.76 and its 200 day moving average price is $366.94.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the previous year, the company earned $5.50 earnings per share. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's payout ratio is currently 12.11%.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent research reports. Royal Bank Of Canada dropped their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Wells Fargo & Company decreased their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Finally, Barclays increased their target price on HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and an average price target of $407.75.

View Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.